Top compounds associated with response to RP5-966M1.6


Feature Type Standardized
Nominal ANOVA
mRNA dacarbazine CTRPv2 pan-cancer AAC 0.15 6e-06
mRNA barasertib CTRPv2 pan-cancer AAC 0.15 1e-05
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 3e-05
mRNA AZD6482 CTRPv2 pan-cancer AAC 0.16 3e-05
mRNA BRD-K01737880 CTRPv2 pan-cancer AAC 0.5 4e-05
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 8e-05
mRNA nelarabine CTRPv2 pan-cancer AAC 0.16 9e-05
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 9e-05
mRNA VX-680 CTRPv2 pan-cancer AAC 0.48 0.0001
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.14 0.0002
Download CSV